Table 3 Histopathological findings from thyroidectomy patients in Southern Iran
From: The diagnostic role of FNA based on clinicopathological features in thyroid malignancy
Group | Subgroup | Frequency (%); N = 310 | ||
|---|---|---|---|---|
Malignancy | Total | 181 | ||
Differentiated | Derived From Follicular Epithelioma | Papillary thyroid carcinoma Conventional | 157 (50.6) | |
Hurtle Cell Carcinoma | 1 (0.3) | |||
Papillary thyroid carcinoma Follicular Variant with Capsular Vascular Invasion | 12 (3.9) | |||
Follicular Thyroid Carcinoma | 2 (0.6) | |||
Derived From Parafollicular Epithelioma | Medullary Thyroid Carcinoma | 7 (2.3) | ||
Undifferentiated | Anaplastic Thyroid Cancer | 2 (0.6) | ||
Non-Malignant | Total | 100 | ||
Colloid Goiter | 4 (1.3) | |||
Follicular Adenoma | 4 (1.3) | |||
Multinodular Goiter | 78 (25.2) | |||
Hashimoto | 4 (1.3) | |||
Hurthle Cell Adenoma | 1 (0.3) | |||
Adenomatous Goiter | 4 (1.3) | |||
Lymphocytic Thyroiditis | 1 (0.3) | |||
Hyperplastic Nodule | 1 (0.3) | |||
Cystic Fluid | 1 (0.3) | |||
Graves | 2 (0.6) | |||
Mixed | Papillary thyroid carcinoma + Follicular Carcinoma | 1 (0.3) | ||
Papillary thyroid carcinoma + Multinodular Goiter | 1 (0.3) | |||
Hashimoto + Hurthle Cell Adenoma | 2 (0.6) | |||
PTC and Anaplastic carcinoma | 1 (0.3) | |||
Multinodular Goiter + Hyperplastic nodule | 3 (1) | |||
Multinodular Goiter + Squamous Metaplasia | 1 (0.3) | |||
Multinodular Goiter + Lymphocytic thyroiditis | 6 (1.9) | |||
Multinodular Goiter + Hashimoto | 7 (2.3) | |||
Colloid goiter + Hyperplastic nodule | 1 (0.3) | |||
Colloid goiter + Hyperplastic nodule + Lymphocytic thyroiditis | 1 (0.3) | |||
Nonthyroidal | Parathyroid Adenoma | Non-Malignant | 1 (0.3) | |
Premalignant | Follicular Neoplasm (non-invasive follicular thyroid neoplasm with papillary like nuclear features) | 4 (1.3) | ||